Botox, the brand name of a medicine which contains Botulinum Toxin is made from the bacteria that causes botulism. The Botulinum toxin is used to block nerve activity in the muscles. It is used in adults for treatment of cervical dystonia (severe spasms in the neck muscles), or muscle stiffness in the elbows, fingers, wrists, ankles, or toes. It has been used to treat overactive bladder & incontinence (urine leakage) due to nerve disorders like spinal cord injury or multiple sclerosis, to treat severe underarm sweating (hyperhidrosis), to avoid chronic migraine headaches in adults who have migraines for more than 15 days in a month, each lasting 4 hours or longer. It is also used in treatment of certain eye muscle conditions triggered by nerve disorders in adults & children who are at least 12 years old, including uncontrolled blinking or spasm of the eyelids, as well as a condition where the eyes do not point in the same direction. Botox is also used to temporarily lessen the presence of facial wrinkles in adults.This growth is primarily driven by Increasing demand for slightly intrusive or non-obtrusive technique
|Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility
The Pharmaceuticals sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Allergan Plc (Ireland), Daewoong Pharmaceutical Co., Ltd. (South Korea), HUGEL, Inc. (South Korea), Ipsen Group (France), Medy-Tox Inc. (South Korea), Merz Pharma GmbH & Co. KGaA (Germany), Metabiologics, Inc. (United States) and Revance Therapeutics, Inc. (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
In December 2022, Gufic Biosciences introduced its domestically produced botulinum toxin type A (Botox) injection in India. The Botox product by Gufic will be available for purchase in India under the brand name 'Zarbot'. A notable characteristic of 'Zarbot' is its manufacturing process, which utilizes purified HALL strain and proprietary technology. This approach leads to a thin film formulation and enhanced stability, distinguishing it from other brands of botulinum toxin., and In January 2023, AbbVie and Immunome, Inc., a clinical-stage biopharmaceutical company specializing in the discovery and development of innovative antibody therapeutics through its human memory B cell platform, have entered into a global collaboration and option agreement. The partnership aims to discover and develop up to 10 new antibody-target pairs derived from three specific tumor types using Immunome's Discovery Engine.In December 2018, Daewoong Pharmaceutical Co., Ltd. has announced that it signed an export contract to New Zealand, Israel (including Palestine), & Ukraine with Nabota, its botulinum toxin product. This is a 12 million-dollar, 5-year export contract, & Daewoong Pharmaceutical Co., Ltd. is targeting to acquire permit as well as launch the product by 2020. Through this contract, the company will be in charge of production & supply and the local partner will be in charge of permit and sales.
Market Growth Drivers:
Increasing demand for slightly intrusive or non-obtrusive technique, Availability of wide variety of slightly intrusive or non-obtrusive technique treatment alternatives and Increasing therapeutic use of botulinum toxin
Life threatening serious side effects of Botox and Natural & needle-free alternatives available in the market
Potential Applications in dentistry & oral and maxillofacial surgery
AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.
Data Sources of Botox Market Study
Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Botox Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.The primary interviews and data collected as per the below protocols:
By Designation: C-Level, D-Level, Others
By Company Type: Tier 1, Tier 2, Tier 3
Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Botox players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.
Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Botox Study Sheds Light on
The Botox Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Botox industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Botox industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.